IL199414A - Kit for the determination of thrombospondin fragments in sample of human material - Google Patents

Kit for the determination of thrombospondin fragments in sample of human material

Info

Publication number
IL199414A
IL199414A IL199414A IL19941409A IL199414A IL 199414 A IL199414 A IL 199414A IL 199414 A IL199414 A IL 199414A IL 19941409 A IL19941409 A IL 19941409A IL 199414 A IL199414 A IL 199414A
Authority
IL
Israel
Prior art keywords
kit
determination
sample
human material
thrombospondin fragments
Prior art date
Application number
IL199414A
Other languages
Hebrew (he)
Other versions
IL199414A0 (en
Original Assignee
W2 Holdings Inc
Kevin J Williams
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by W2 Holdings Inc, Kevin J Williams filed Critical W2 Holdings Inc
Publication of IL199414A0 publication Critical patent/IL199414A0/en
Publication of IL199414A publication Critical patent/IL199414A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4728—Details alpha-Glycoproteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL199414A 2002-08-23 2009-06-17 Kit for the determination of thrombospondin fragments in sample of human material IL199414A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40549402P 2002-08-23 2002-08-23
US10/419,462 US7655411B2 (en) 2002-08-23 2003-04-21 Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
PCT/US2003/026023 WO2004018995A2 (en) 2002-08-23 2003-08-20 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents

Publications (2)

Publication Number Publication Date
IL199414A0 IL199414A0 (en) 2011-07-31
IL199414A true IL199414A (en) 2015-07-30

Family

ID=31949896

Family Applications (2)

Application Number Title Priority Date Filing Date
IL166982A IL166982A (en) 2002-08-23 2005-02-17 Thrombospondin fragments and binding agents for the detection, diagnosis and evaluation of cancer
IL199414A IL199414A (en) 2002-08-23 2009-06-17 Kit for the determination of thrombospondin fragments in sample of human material

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IL166982A IL166982A (en) 2002-08-23 2005-02-17 Thrombospondin fragments and binding agents for the detection, diagnosis and evaluation of cancer

Country Status (11)

Country Link
US (8) US7655411B2 (en)
EP (1) EP1572225B1 (en)
AU (1) AU2003262727A1 (en)
CA (1) CA2496984C (en)
CY (1) CY1116133T1 (en)
DK (1) DK1572225T3 (en)
ES (1) ES2533452T3 (en)
IL (2) IL166982A (en)
PT (1) PT1572225E (en)
SI (1) SI1572225T1 (en)
WO (1) WO2004018995A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655411B2 (en) 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
MX2007005865A (en) * 2004-11-16 2008-02-25 Amben Mountain View Inc Protein scaffolds and uses therof.
GB0523828D0 (en) * 2005-11-23 2006-01-04 Ares Trading Sa Thrombospondin domain-containing cell surface recognition molecules
US7811549B2 (en) 2006-07-05 2010-10-12 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
AU2007319576B2 (en) 2006-10-06 2014-01-16 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Prevention of tissue ischemia, related methods and compositions
EP1930729A1 (en) * 2006-12-04 2008-06-11 Medizinische Universität Wien Method for in vivo and in vitro testing for a pharmaceutical drug induced immediate type hypersensitivity reactions
WO2009092516A2 (en) * 2008-01-22 2009-07-30 Adenobio N.V. Methods, compositions, unit dosage forms, and kits for pharmacologic stress testing with reduced side effects
EP2347260A4 (en) * 2008-10-21 2012-09-26 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2014160183A1 (en) * 2013-03-13 2014-10-02 The United States Of America,As Represented By The Secretary,Department Of Health And Human Services Methods for modulating chemotherapeutic cytotoxicity
CN104075931B (en) * 2013-03-29 2016-08-03 中国科学院大连化学物理研究所 A kind of protein example rapid preprocessing method in situ
CN106885908B (en) * 2015-12-23 2019-05-07 中国人民解放军第二军医大学 The detection kit and its detection method of blood-serum P SMD4 albumen and application
CN105801694A (en) * 2016-05-03 2016-07-27 上海科新生物技术股份有限公司 Chimeric antibody of anti-cardiolipin/beta2 glycoprotein I complex

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610960A (en) 1983-12-21 1986-09-09 Wisconsin Alumni Research Foundation Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
US4820505A (en) 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
US5192744A (en) 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5840692A (en) 1990-02-22 1998-11-24 Allegheny University Of The Health Sciences Peptide fragments and analogs of thrombospondin
US6239110B1 (en) 1990-02-22 2001-05-29 W.R. Grace & Co. -Conn. Synthetic analogs of thrombospondin and therapeutic use thereof
US5256538A (en) 1991-03-08 1993-10-26 Board Of Regents, The University Of Texas System Detection of early platelet activation and prediagnosis of thrombotic events
CA2063055A1 (en) 1991-05-22 1992-11-23 Jacob Eyal Peptides having thrombospondin-like activity and their therapeutic use
US5770563A (en) 1991-12-06 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof
DE4203545A1 (en) 1992-02-07 1993-08-12 Behringwerke Ag SPECIFIC ANTIBODIES AGAINST ACTIVATED PLATES, THEIR PRODUCTION AND THEIR USE IN DIAGNOSIS AND THERAPY
US5279966A (en) 1992-04-02 1994-01-18 The Trustees Of Columbia University In The City Of New York Cloning, expression and uses of a novel secreted protein, F-spondin
US5753517A (en) 1996-03-29 1998-05-19 University Of British Columbia Quantitative immunochromatographic assays
ATE259505T1 (en) * 1996-08-15 2004-02-15 Novartis Pharma Gmbh TEST FOR QUANTIFYING ARTHRITIS CONDITIONS
US5840507A (en) 1997-03-19 1998-11-24 Oncotech, Inc. Methods for cancer prognosis and diagnosis
US5922551A (en) * 1997-03-20 1999-07-13 Accumetrics, Inc. Agglutrimetric platelet binding assays in blood
US6339062B1 (en) 1998-11-23 2002-01-15 Inkine Pharmaceutical Company, Inc. Retroinverso polypeptides that mimic or inhibit thrombospondin activity
MXPA01001885A (en) 1999-06-21 2002-04-24 Inkine Pharmaceutical Company Angiocidin: a cysservalthrcysgly specific tumor cell adhesion receptor.
DE60031576D1 (en) 1999-08-30 2006-12-07 Wesagen Diagnostisches assay für typ-2-heparin induzierte thrombocytopenie
US6727063B1 (en) * 1999-09-10 2004-04-27 Millennium Pharmaceuticals, Inc. Single nucleotide polymorphisms in genes
US20010041670A1 (en) 1999-12-06 2001-11-15 Ronit Simantov Thrombospondin-binding region of histidine-rich glycoprotein and method of use
AU2002220266A1 (en) * 2000-11-09 2002-05-21 Millennium Pharmaceuticals, Inc. Methods for the identification and the treatment of cardiovascular disease
US20030119074A1 (en) 2001-12-20 2003-06-26 George Jackowski Diagnosis and treatment of dementia utilizing thrombospondin
US7655411B2 (en) 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer

Also Published As

Publication number Publication date
US8053196B2 (en) 2011-11-08
AU2003262727A8 (en) 2004-03-11
IL166982A (en) 2014-09-30
EP1572225A2 (en) 2005-09-14
AU2003262727A1 (en) 2004-03-11
US20120271124A1 (en) 2012-10-25
US8415107B2 (en) 2013-04-09
ES2533452T3 (en) 2015-04-10
CA2496984A1 (en) 2004-03-04
US20050065324A1 (en) 2005-03-24
PT1572225E (en) 2015-04-07
DK1572225T3 (en) 2015-03-30
US20060257947A1 (en) 2006-11-16
EP1572225B1 (en) 2014-12-24
IL199414A0 (en) 2011-07-31
CA2496984C (en) 2014-12-09
CY1116133T1 (en) 2017-02-08
US20100155245A1 (en) 2010-06-24
WO2004018995A2 (en) 2004-03-04
US20140051098A1 (en) 2014-02-20
WO2004018995A3 (en) 2004-09-10
US20120276559A1 (en) 2012-11-01
US20110065206A1 (en) 2011-03-17
SI1572225T1 (en) 2015-05-29
US7655411B2 (en) 2010-02-02
EP1572225A4 (en) 2009-07-01
US20040053392A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
IL199414A (en) Kit for the determination of thrombospondin fragments in sample of human material
EP1539003A4 (en) Microdermabrasion composition and kit
HK1091894A1 (en) Prion protein binding materials and methods of use
EP1736541A4 (en) Novel galectin 9 modification protein and use thereof
EP1767634A4 (en) Novel galectin 8 modification protein and use thereof
EP1604710A4 (en) Skin material for ball and ball
GB0307352D0 (en) Improvements in and relating to the analysis of compounds
GB0326780D0 (en) Biological materials and uses thereof
GB0307311D0 (en) Ultrasound probe and application thereof
GB2393571B (en) Improvements in and relating to the control of instruments
GB2400659B8 (en) Assay methods and materials
EP1633850A4 (en) Ovr115 ANTIBODY COMPOSITION AND METHODS OF USE
GB0326778D0 (en) Biological materials and uses thereof
AU2003236912A8 (en) Francisella tularensis immunogenic proteins and dna encoding these
GB0229444D0 (en) Diagnostic method and assay kit
GB0204698D0 (en) Improvements in and relating to material testing
EP1577322A4 (en) Novel proteins and use thereof
EP1541677A4 (en) Novel proteins and use thereof
AU2003260487A8 (en) Novel pancortin-pablo protein interactions and methods of use thereof
AU2003263751A8 (en) Novel proteins and their uses
AU2002245270A1 (en) Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer
GB0223607D0 (en) Testing of samples
AU2003262895A8 (en) Carboxypeptidase b related polypeptides and methods of use
AU2003903934A0 (en) Protein fragments and uses thereof
AU2003904023A0 (en) Protein fragments and uses thereof ii

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees